Diseases, Conditions, Syndromes

Ending tuberculosis is a race against time and drug resistance

The tuberculosis (TB) burden in the WHO European Region as a whole is decreasing, and is down 19% overall for 2015-2019, according to the latest WHO/European Center for Disease Prevention and Control (ECDC) report Tuberculosis ...

Diseases, Conditions, Syndromes

S.Africa trial shows promise for drug-resistant TB regimen

Almost all patients who received a new treatment for highly drug-resistant tuberculosis are still clear of the disease two years after a medical trial in South Africa, findings from a long-term study showed Thursday.

Medications

New tuberculosis drug regimen slashes treatment time

Tuberculosis is an age-old respiratory scourge, with a new twist: growing resistance to multiple first- and second-line drugs. UF researchers and physicians report on using a novel treatment to slash treatment time—and ...

Medical research

Fighting the good fight against bacteria

Drug-resistant bacteria could lead to more deaths than cancer by 2050, according to a report commissioned by the United Kingdom in 2014 and jointly supported by the U.K. government and the Wellcome Trust. In an effort to ...

Diseases, Conditions, Syndromes

Drug-resistant tuberculosis reversed in lab

About 1.5 million people died of tuberculosis (TB) in 2017, making it the most lethal infectious disease worldwide. A growing rise in drug-resistant TB is a major obstacle to successfully treating the illness.

Diseases, Conditions, Syndromes

Promising new drugs for old pathogen Mtb

Tuberculosis (TB), an ancient and notoriously difficult disease to treat, has killed millions through the course of human history; and the antibiotics that have been used to fight the disease in recent history are becoming ...

page 3 from 13